Combined bone marrow and solid organ transplantation with alemtuzumab induction

Ron Shapiro, Velma P. Scantlebury, Mark L. Jordan, Robert J. Corry, Santosh Potdar, Ashokkumar Jain, Carlos A. Vivas, Parmjeet Randhawa, Amit Basu, Cynthia Smetanka, Edward A. Gray, Noriko Murase, Jennifer Woodward, Adriana Zeevi, Anthony J. Demetris, John J. Fung, Amadeo Marcos, Thomas E. Starzl

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


In summary, a combination of high-dose antibody therapy as a preconditioning agent and low-dose tacrolimus as a maintenance therapy appears to allow slow tapering of immunosuppression to remarkably low levels.

Original languageEnglish (US)
Pages (from-to)S18-S19
JournalTransplantation Reviews
Issue number4 SUPPL.
StatePublished - Oct 2003

All Science Journal Classification (ASJC) codes

  • Transplantation


Dive into the research topics of 'Combined bone marrow and solid organ transplantation with alemtuzumab induction'. Together they form a unique fingerprint.

Cite this